Nightingale Health Eo Stock Price To Sales
| 7XE Stock | EUR 2.81 0.12 4.10% |
NIGHTINGALE HEALTH EO fundamentals help investors to digest information that contributes to NIGHTINGALE HEALTH's financial success or failures. It also enables traders to predict the movement of NIGHTINGALE Stock. The fundamental analysis module provides a way to measure NIGHTINGALE HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NIGHTINGALE HEALTH stock.
NIGHTINGALE |
NIGHTINGALE HEALTH EO Company Price To Sales Analysis
NIGHTINGALE HEALTH's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, NIGHTINGALE HEALTH EO has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Healthcare sector and about the same as Health Information Services (which currently averages 0.0) industry. The price to sales for all Germany stocks is 100.0% higher than that of the company.
NIGHTINGALE Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NIGHTINGALE HEALTH's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NIGHTINGALE HEALTH could also be used in its relative valuation, which is a method of valuing NIGHTINGALE HEALTH by comparing valuation metrics of similar companies.NIGHTINGALE HEALTH is currently under evaluation in price to sales category among its peers.
NIGHTINGALE Fundamentals
| Return On Equity | -0.14 | |||
| Return On Asset | -0.0647 | |||
| Operating Margin | (5.88) % | |||
| Shares Outstanding | 39.09 M | |||
| Shares Owned By Insiders | 50.45 % | |||
| Shares Owned By Institutions | 16.00 % | |||
| Revenue | 2.31 M | |||
| Gross Profit | 1.28 M | |||
| EBITDA | (11.53 M) | |||
| Book Value Per Share | 1.85 X | |||
| Earnings Per Share | (0.25) X | |||
| Target Price | 1.3 | |||
| Number Of Employees | 71 | |||
| Market Capitalization | 66.28 M |
About NIGHTINGALE HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NIGHTINGALE HEALTH EO's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NIGHTINGALE HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NIGHTINGALE HEALTH EO based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in NIGHTINGALE Stock
NIGHTINGALE HEALTH financial ratios help investors to determine whether NIGHTINGALE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NIGHTINGALE with respect to the benefits of owning NIGHTINGALE HEALTH security.